Filing Flows › BioNexus Gene Lab (BGLC) › How it makes money
How BioNexus Gene Lab (BGLC) makes money
BioNexus Gene Lab (BGLC) made $76K of revenue in the second quarter 2026 (Q2 2026), -97% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $76K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $76K | -97% |
| Q1 2026 | $23K | -99% |
| Q4 2025 | $484K | -81% |
| Q3 2025 | $2.5M | -3% |
| Q2 2025 | $2.3M | +14% |
| Q1 2025 | $2.1M | -10% |
| Q4 2024 | $2.5M | +11% |
From BioNexus Gene Lab's 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does BioNexus Gene Lab make money?
BioNexus Gene Lab (BGLC) made $76K of revenue in the second quarter 2026 (Q2 2026), -97% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.